Management of cholesterol to reduce the burden of stroke in Asia: consensus statement

Management of cholesterol to reduce the burden of stroke in Asia: consensus statement

Stroke is a major cause of morbidity and mortality in Asia, and its pattern is changing. The incidence of haemorrhagic stroke is declining while the incidence of ischaemic stroke caused by large artery atherothromboembolism is increasing secondary to an increase in the prevalence of hypercholesterol...

Full description

Saved in:
Bibliographic Details
Published in:International journal of stroke Vol. 5; no. 3; pp. 209 - 216
Main Authors: Hankey, Graeme J., Wong, Ka S. L., Chankrachang, Siwaporn, Chen, Christopher, Crimmins, Denis, Frayne, Judith, Kim, Jong S., Li, Yansheng, Liou, Chia-Wei, Merican, Julia S., Misbach, Jusuf, Navarro, Jose, Shinohara, Yukito, Wang, Yongjun, Yoon, Byung-Woo
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-06-2010
SAGE Publications
Subjects:
Asia
Asia - epidemiology
Cerebral Hemorrhage - complications
Cerebral Hemorrhage - epidemiology
Cholesterol - blood
Consensus
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hypercholesterolemia - complications
Hypercholesterolemia - prevention & control
lipids
prevention
Randomized Controlled Trials as Topic
Risk Factors
Secondary Prevention
statins
stroke
Stroke - epidemiology
Stroke - etiology
Stroke - genetics
Stroke - prevention & control
Asia
lipids
risk factors
Asia
stroke
statins
prevention
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Stroke is a major cause of morbidity and mortality in Asia, and its pattern is changing. The incidence of haemorrhagic stroke is declining while the incidence of ischaemic stroke caused by large artery atherothromboembolism is increasing secondary to an increase in the prevalence of hypercholesterolemia. The Working Group on Stroke and Lipids Management in Asia Consensus Panel assembled leading experts from the region to reach a consensus on how to address this challenge. The group discussed the observational epidemiology of the relationship between cholesterol and risk of stroke, the clinical trial evidence base for cholesterol-lowering for stroke prevention, and issues specific to stroke and lipid management for Asian doctors and patients. Stroke guidelines from many of the Asian countries have recently recommended consideration of statins for recurrent stroke prevention in patients with previous ischaemic stroke or transient ischaemic attack. However, because these recommendations have yet to be
Bibliography:istex:DCA81D18CDD9F86C62CDEDCA620EF859048CB827
ArticleID:IJS429
ark:/67375/WNG-JNJJM7MF-6
Conflict of interest: Siwaporn Chankrachang has received a study grant from Beaufour Ipsen and has served on advisory boards for Pfizer Inc., as well as a co‐investigator for the following research groups: CHIMES, PERFORM, PRoFESS, and ORaCLE. Christopher Chen has received study grants from: Biomedical Research Council; Boehringer‐Ingelheim GmbH; Eisai Inc.; Les Laboratoires Servier; Moleac Pte Ltd.; National Medical Research Council, Singapore; National Research Foundation; Novartis AG; sanofi‐aventis; and UCB S.A. He has also received honoraria for serving on advisory boards for: Boehringer‐Ingelheim GmbH; BrainsGate Ltd.; Daiichi Sankyo Co., Ltd.; Eisai Inc.; Janssen
Division of Ortho‐McNeil‐Janssen Pharmaceuticals, Inc.; Les Laboratoires Servier; Lundbeck Inc.; Novartis AG; sanofi‐aventis; and Takeda Pharmaceutical Company, Ltd. Denis Crimmins has received honoraria for clinical presentations and lectures from Astra, Boehringer‐Ingelheim GmbH, and Pfizer Inc.
®
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-1
ObjectType-Feature-4
content type line 23
ObjectType-Review-2
ObjectType-Article-3
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1747-4930
1747-4949
DOI:10.1111/j.1747-4949.2010.00429.x